Go to home page - PHARMAC - Pharmaceutical Management Agency
Leading Edge Medicines Management home
Patients & Consumers Health Professionals District Health Boards Pharmaceutical Suppliers

Wed May 23 2012 NZST

Search term:

2009 / 10

PHARMAC documents that matched your search:

Prev, Next – Page 1 of 4 (37 documents)

icon

Funding of a new brand of grans for oral liquid amoxycillin 125mg per 5 ml (2 pages, 27 KB)
2009/10/30
archive, notification

30 October 2009 Funding of a new brand of grans for oral liquid amoxycillin 125mg per 5 ml PHARMAC is pleased to announce that the approval of an agreement with Sandoz Pty Limited. This was the subject of a consultation…

text


icon

Notification of proposal relating to Baxter Healthcare’s IV and irrigation fluids (1 page, 96 KB)
2009/10/30
archive, notification

30 October 2009 Proposal relating to Baxter Healthcare’s IV and irrigation fluids PHARMAC has approved a proposal to amend the listing of a number of intravenous (IV) fluids supplied by Baxter Healthcare, and list a number of new irrigation fluids,…

text


icon

October Tender Results (2 pages, 108 KB)
2009/10/30
archive, notification, tender

30 October 2009 TENDER RESULTS The PHARMAC Board (or Chief Executive under delegated authority) has resolved to accept tenders for Sole Subsidised Supply and Hospital Supply Status for some of the products listed in the Invitation to Tender dated 21…

text


icon

Funding proposal for clindamycin, sulphasalazine, cabergoline and medroxyprogesterone. Closed (3 pages, 163 KB)
2009/10/29
consultation

29 October 2009 Funding proposal for clindamycin (Dalacin C), sulphasalazine (Salazopyrin), cabergoline (Dostinex) and medroxyprogesterone PHARMAC is seeking feedback on a proposal to amend the prices and subsidies for clindamycin (Dalacin C), cabergoline (Dostinex), sulphasalazine (Salazopyrin and Salazopyrin EN) and…

text


icon

PHARMAC pays tribute to health professionals’ role in brand changes (2 pages, 109 KB)
2009/10/29
media

29 October 2009 Media release PHARMAC pays tribute to health professionals’ role in brand changes PHARMAC is acknowledging the role health professionals played in implementing medicine brand changes that affected a very large number of New Zealanders during 2008/09. Highlights…

text


icon

Proposal for Arrow-Topiramate and Arrow-Alprazolam. Closed (2 pages, 57 KB)
2009/10/29
archive, consultation

29 October 2009 Proposal for Arrow-Topiramate and Arrow-Alprazolam PHARMAC is seeking feedback on a proposal to fund a new brand of topiramate tablets and reduce the price and subsidy for alprazolam through a provisional agreement with Arrow Pharmaceuticals (NZ) Limited.…

text


icon

Proposal for sole supply arrangement for somatropin. Closed (3 pages, 179 KB)
2009/10/29
archive, consultation

29 October 2009 Proposal for sole supply arrangement for somatropin PHARMAC and Pfizer New Zealand Limited have entered into a provisional agreement for the ongoing funding of Genotropin, one of two brands of somatropin (also known as human growth hormone)…

text


icon

Proposal relating to cyclosporin A, octreotide LAR and zoledronic acid. Closed (2 pages, 154 KB)
2009/10/29
consultation

29 October 2009 Proposal relating to cyclosporin A, octreotide LAR and zoledronic acid PHARMAC and Novartis New Zealand Limited have entered into a provisional agreement relating to the supply of Neoral (cyclosporin A 25 mg, 50 mg and 100 mg…

text


icon

Proposal relating to provisional agreement with API Consumer Brands Limited for the listings of various pharmaceuticals. Closed (2 pages, 158 KB)
2009/10/29
consultation

29 October 2009 Proposal relating to provisional agreement with API Consumer Brands Limited for the listings of various pharmaceuticals on the Pharmaceutical Schedule PHARMAC is seeking feedback on a proposal involving cholecalciferol (Cal-d-Forte), codeine phosphate (PSM), dexamphetamine sulphate (PSM), glycerol…

text


icon

Annual Report - year ended 30 June 2009 (55 pages, 3268 KB)
2009/10/28

E.59 Pharmaceutical Management Agency Annual Report For the year ended 30 June 2009 Presented to the House of Representatives pursuant to Section 150(3) of the Crown Entities Act 2004 Pharmaceutical Management Agency Level 9, 40 Mercer Street, PO Box 10-254,…

text


Prev, Next – Page 1 of 4 (37 documents)

Search tips

Search or Browse

To search for a document enter a search term into the search form and activate the Search button.

Documents may be browsed by date, eg; Today, May, 2012.

Past years can be browsed too...
2011, 2010, 2009, 2008, 2007, 2006, 2005, 2004, 2003, 2002, 2001, 2000, 1999, 1998, 1997, 1996, 1995, 1994.

Documents can be searched within a period by browsing to the date and then using the search form; or by direct links, eg;
Media releases from 2012

Search terms

Parentheses and the keywords and, or and not have special meaning in search terms. And is implicit and can be omitted; or must be specified.

Document tags (shown in bolded red below document date) have highest priority when search results are ranked, followed by title, abstract and full text of document (if available). Tags in use include...
AnnualReview, archive, BoardPaper, BusinessPlan, CAC, CACminutes, CCNotifications, ClinNewsletter, consultation, EC, EOI, etender, herceptin, inpharmation, leaflet, LetterOfExpectations, media, notification, NPPA, OIA, OutputAgreement, PatientGuide, policy, PTAC, PTACminutes, PTACSCMinutes, Q&A, release, resource, RFI, RFP, SAForm, SAForms, schedule, ScheduleDispatch, SchedulePublications, SectionH, SOI, TdrNotification, tender, update, vacancy, WhatsNew.

Documents with related dates can be browsed through the date component links below the document title.

Remember to group or statements with parentheses if they are beside and statements.

Search examples

consultation
Search for consultations
media and not antibiotics
Search for media related documents that don't mention antibiotics.
(media or consultation) and vaccines
Search for media releases and consultation documents mentioning vaccinations.